IDXX Stock Chart & Fundamental Analysis

Interactive Chart

About IDEXX Laboratories Inc

Name

IDEXX Laboratories Inc

CEO

Jonathan J. Mazelsky

Website

www.idexx.com

Industry

Healthcare

Year Founded

1983

Employees

11,000

IDEXX Laboratories, Inc. (NASDAQ: IDXX) develops diagnostic and information products for animal health and water testing within the medical diagnostics and research business, generating $4.3 billion in FY2025 revenue. Its work spans veterinary care, livestock and dairy monitoring, biomedical research support, and microbiological testing tools used in water quality programs worldwide.

Analyst Ratings

Consensus Recommendation

Buy2

Hold2

Sell3

Fundamentals & Financials

Revenue (TTM)

$4.4B

Net Income (TTM)

$1B

EPS (TTM)

$13.67

ROA (TTM)

32.35%

Current Ratio

1.12

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q1 FY2026	Q4 FY2025	Q3 FY2025
Revenue	$1,140.8M	$1,090.5M	$1,105.2M
Cost of Sales	$418,081K	$432,465K	$421,885K
Gross Profit	$722,739K	$658,114K	$683,354K
Operating Income	$362,586K	$315,605K	$354,846K
Net Income	$278,446K	$248,188K	$274,610K
EPS	$3.48	$3.1	$3.43

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

IDEXX Laboratories Inc's Technical Indicators Summary

IDXX shows a sell bias mostly because longer-term averages remain notably above the current level despite some short-term strength. The MACD is negative and ADX indicates only a weak trend, while short-term moving averages sit near or below price but the 100- and 200-day averages are well above, implying longer-term resistance. Volatility is moderate and on-balance volume is positive, creating a mixed backdrop, and the pivot lies below the price. Technical takeaway: Sell stance driven by higher long-term moving averages and weakening trend signals despite short-term support.

Buy

2 signals

Neutral

2 signals

Sell

3 signals

Overall: Bearish43% Bearish signals

Indicator	Value	Signal	Explanation
RSI (14)	51.89	Neutral	RSI (51.89) is neutral.
Stochastic %K (14, 3, 3)	39.61	Neutral	Stochastic (39.61) is neutral.
CCI (20)	-23.07	Neutral	CCI (-23.07) is neutral.
WPR (14)	-29.32	Neutral	Williams %R (-29.32) is neutral.
Momentum (10)	11.71	Buy	Momentum (11.71) is positive.
MFI	49.18	Neutral	MFI (49.18) is neutral.
MACD Level (12, 26)	-4.53	Sell	Confirmed downtrend: MACD (-4.53) is negative and below its signal line (-3.47).
Bollinger Bands	$528.40 - $581.03	Neutral	Price is within the bands.
ATR (14)	$17.74 (3.18%)	Neutral	Moderate Volatility (3.18%).
ADX (14)	11.59	Neutral	Weak or consolidating trend (ADX < 25). ADX(11.59), +DI(23.86), -DI(22.08)
OBV	6,150,468	Buy	Bullish volume pressure: OBV is above its 20-day SMA. OBV(6,150,468), 20D-SMA-OBV(5,999,828)
Classic Pivot Point	$535.13	Buy	Price ($557.80) has broken above resistance R1 ($541.54) — bullish breakout potential.
Fibonacci Pivot Point	$535.13	Buy	Price ($557.80) has broken above resistance R1 ($539.09) — bullish breakout potential.
Exponential Moving Averages	$547.04 - $605.29(5 indicators)	Sell	EMA group: 3/5 bearish, 2 bullish, 0 neutral. Price below key EMA averages.
Simple Moving Averages	$546.25 - $628.05(5 indicators)	Buy	SMA group: 3/5 bullish, 2 bearish, 0 neutral. Price above key SMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

By the bell, IDXX remained above yesterday’s close, carrying forward the 3.76% upside gap. By the close, sector strength was clear, with a 2.65% gain underpinning risk appetite. The session ended with IDXX at a demanding PE of 51.37.

Trading Volume

vs S&P 500 Today

Strong Outperformance

+20.55%

52-Week Position

Lower range

19.3%

Updated: July 2, 2026 at 20:12 UTC